Research Article
Recent Trends in the Clinicopathological Features of Thyroid Nodules in Pediatric Patients: A Single Tertiary Center Experience over 25 Years
Table 4
Clinicopathological features of the pediatric patients with thyroid nodules according to the period of diagnosis.
| | 1990 to 1995 (n = 42) | 1996 to 2000 (n = 50) | 2001 to 2005 (n = 40) | 2006 to 2010 (n = 38) | 2011 to 2014 (n = 45) | value |
| Age, years (mean, SD) | 15 | ±3.624 | 15 | ±3.138 | 15 | ±3.342 | 15 | ±2.857 | 15 | ±3.078 | 0.218 | Age groups | | | | | | | | | | | 0.892 | 0–10 | 4 | 9.5% | 8 | 16.0% | 4 | 10.0% | 3 | 7.9% | 5 | 11.1% | | 11–15 | 17 | 40.5% | 16 | 32.0% | 12 | 30.0% | 16 | 42.1% | 18 | 40.0% | | 16–18 | 21 | 50.0% | 26 | 52.0% | 24 | 60.0% | 19 | 50.0% | 22 | 48.9% | | Sex | | | | | | | | | | | 0.149 | Females | 35 | 83.3% | 35 | 70.0% | 35 | 87.5% | 32 | 84.2% | 31 | 68.9% | | Males | 9 | 21.4% | 15 | 30.0% | 5 | 12.5% | 6 | 15.8% | 14 | 31.1% | | Chief complaint leading to hospital admission | | | | | | | | 0.061 | | | | Incidentaloma | 0 | | 1 | 2.0% | 3 | 7.5% | 6 | 15.8% | 11 | 24.4% | | Anterior neck palpable mass | 37 | 88.1% | 42 | 84.0% | 33 | 82.5% | 26 | 68.4% | 27 | 60.0% | | Lateral neck palpable mass | 1 | 2.4% | 2 | 4.0% | 0 | | 2 | 5.3% | 2 | 4.4% | | Neck discomfort | 0 | | 0 | | 0 | | 2 | 5.3% | 1 | 2.2% | | Hoarseness | 0 | | 1 | 2.0% | 0 | | 0 | | 1 | 2.2% | | Dyspnea | 1 | 2.4% | 0 | | 1 | 2.5% | 0 | | 1 | 2.2% | | Unknown | 3 | 7.1% | 4 | 8.0% | 3 | 7.5% | 2 | 5.3% | 2 | 4.4% | | Fine needle aspiration at admission | | | | | | | | | ≤0.00 | | | Yes | 17 | 40.5% | 36 | 72.0% | 31 | 77.5% | 36 | 94.7% | 41 | 91.1% | | No | 25 | 59.5% | 14 | 28.0% | 9 | 22.5% | 2 | 5.3% | 4 | 8.9% | | Initial cytology | | | | | | | | | | | ≤0.00 | Nondiagnostic or unsatisfactory | 0 | | 1 | 2.8% | 0 | | 0 | | 0 | | | Benign | 7 | 41.2% | 6 | 16.7% | 4 | 12.9% | 3 | 8.3% | 3 | 7.3% | | Atypia of undetermined significance or follicular lesion of undetermined significance | 1 | 5.9% | 1 | 2.8% | 6 | 19.4% | 2 | 5.6% | 5 | 12.2% | | Follicular neoplasm or suspicion of follicular neoplasm | 2 | 11.8% | 8 | 22.2% | 2 | 6.5% | 2 | 5.6% | 3 | 7.3% | | Suspicion of malignancy | 2 | 11.8% | 2 | 5.6% | 1 | 3.2% | 2 | 5.6% | 4 | 9.8% | | Malignant | 5 | 29.4% | 16 | 44.4% | 18 | 58.1% | 27 | 75.0% | 26 | 63.4% | | Others (schwannoma and abscess) | 0 | | 2 | 5.6% | 0 | | 0 | | 0 | | | Final pathology after thyroidectomy | | | | | | | | | | | ≤0.00 | Benign | 32 | 76.2% | 24 | 48.0% | 16 | 40.0% | 5 | 13.2% | 10 | 22.2% | | Graves’ disease (diffuse hyperplasia) | 13 | 40.6% | 12 | 50.0% | 7 | 43.8% | 1 | 20.0% | 4 | 40.0% | | Adenomatous goiter/nodular hyperplasia | 13 | 40.6% | 5 | 20.8% | 3 | 18.8% | 3 | 60.0% | 2 | 20.0% | | Hashimoto thyroiditis | 1 | 3.1% | 1 | 4.2% | 0 | | 0 | | 0 | | | Follicular adenoma | 5 | 15.6% | 2 | 8.3% | 6 | 37.5% | 1 | 20.0% | 4 | 40.0% | | Hurthle cell adenoma | 0 | | 2 | 8.3% | 0 | | 0 | | 0 | | | Other (schwannoma and abscess) | 0 | | 2 | 8.3% | 0 | | 0 | | 0 | | | Malignant | 10 | 23.8% | 27 | 54.0% | 24 | 60.0% | 33 | 86.8% | 35 | 77.8% | | Papillary thyroid cancer | 8 | 80.0% | 20 | 74.1% | 20 | 83.3% | 28 | 84.8% | 29 | 82.9% | | Follicular thyroid cancer | 2 | 20.0% | 4 | 14.8% | 4 | 16.7% | 5 | 15.2% | 6 | 17.1% | | Papillary and follicular thyroid cancer | 0 | | 1 | 3.7% | 0 | | 0 | | 0 | | | Tumor size by pathology after thyroidectomy (cm) | 2.5 | (1.2–4.0) | 2.5 | (1.0–6.5) | 3.0 | (1.0–6.0) | 2.5 | (0.5–6.0) | 2.6 | (0.4–8.0) | 0.849 |
|
|